Multi-Probiotic 4000
Friendly flora to promote intestinal balance
Each Multi-Probiotic 4000 capsule contains over four billion
beneficial organisms, including representatives of
both the lactobacillus and bifidobacterium genera,
mixed in a base of prebiotic fructooligosaccharide.
BENEFITS
Oral supplements of live, beneficial intestinal microorganisms
for nutritional health and well-being are
known as probiotics. Probiotic dietary lactobacilli
colonize the intestinal tract, depending on the specific
bacterium-to-host affinity. Bacteria are continually in
competition for colonization space. The original
bacterial colonies have an advantage over transient
bacteria. Nevertheless, the composition of the
intestinal microflora is dynamic and constantly
changing.
If harmful microorganisms proliferate, the
equilibrium is disturbed, and it becomes difficult
even for indigenous bacteria to maintain their
necessary territory to colonize the intestine.
Antibiotics tend to kill off both beneficial and
harmful bacteria, and thus may also disturb the
normal, healthy balance of intestinal microorganisms.
When potent probiotic supplements, such as Multi-
Probiotic 4000, are supplied regularly, chances are
greatly increased for establishing and maintaining a
healthy population of beneficial intestinal
microorganisms.
Once established, a normal
intestinal microflora rich in lactobacilli creates acidic
conditions that are unfavorable for the settlement of
pathogenic microorganisms.
INDICATIONS
Multi-Probiotic 4000 capsules may be a useful
dietary supplement for those who wish to support
their intestinal microflora with meaningful amounts
of beneficial microorganisms.
FORMULA
Each Multi-Probiotic 4000 capsule contains over 4
billion (4000 x 1 million) organisms in the
following potencies:
Lactobacillus. acidophilus (DDS-1)........1.15 Billion
L. Rhamnosus...............................................1.15 Billion
L. Rhamnosus (Type B, Bifidus) .................775 Million
Bifidobacterium lactis..................................275 Million
Bifidobacterium longum ..............................275 Million
B. Bifidum.....................................................275 Million
Streptococcus thermophilus.........................150 Million
In a base of FOS (fructooligosaccharides), special
carbohydrates, enzymes and ulmus fulva
SUGGESTED USE
Adults take 1capsule daily or as directed by
physician.
SIDE EFFECTS
No adverse effects have been reported
STORAGE
Store in a cool, dry place, away from direct light.
Keep out of reach of children.
References
Cebra JJ. Influences of microbiota on intestinal immune system
development. Am J Clin Nutr 1999;69:1046S-1051S.
Collins MD, Gibson GR. Probiotics, prebiotics, and synbiotics:
approaches for modulating the microbial ecology of the gut. Am J
Clin Nutr 1999;69:1052S-1057S.
Donnet-Hughes A, Rochat F, Serrant P, Aeschlimann JM, Schiffrin
EJ. Modulation of nonspecific mechanisms of defense by lactic
acid bacteria: effective dose. J Dairy Sci 1999;82:863-9.
Elmer GW, Surawicz CM, McFarland LV. Biotherapeutic agents.
A neglected modality for the treatment and prevention of selected
intestinal and vaginal infections [see comments]. Jama
1996;275:870-6.
Gibson GR. Dietary modulation of the human gut microflora using
prebiotics. Br J Nutr 1998;80:S209-12.
Goldin BR. Health benefits of probiotics. Br J Nutr 1998;80:S203-7.
Jacobsen CN, Rosenfeldt Nielsen V, Hayford AE, Moller PL,
Michaelsen KF, Paerregaard A, Sandstrom B, Tvede M, Jakobsen
M. Screening of probiotic activities of forty-seven strains of
lactobacillus spp. by In vitro techniques and evaluation of the
colonization ability of five selected strains in humans [In Process
Citation]. Appl Environ Microbiol 1999;65:4949-56.
Kirjavainen PV, Ouwehand AC, Isolauri E, Salminen SJ. The
ability of probiotic bacteria to bind to human intestinal mucus.
FEMS Microbiol Lett 1998;167:185-9.
Pessi T, Sutas Y, Saxelin M, Kallioinen H, Isolauri E.
Antiproliferative effects of homogenates derived from five strains
of candidate probiotic bacteria [In Process Citation]. Appl Environ
Microbiol 1999;65:4725-8.
Tejada-Simon MV, Lee JH, Ustunol Z, Pestka JJ. Ingestion of
yogurt containing Lactobacillus acidophilus and Bifidobacterium
to potentiate immunoglobulin A responses to cholera toxin in mice.
J Dairy Sci 1999;82:649-60.
Venturi A, Gionchetti P, Rizzello F, Johansson R, Zucconi E,
Brigidi P, Matteuzzi D, Campieri M. Impact on the composition of
the faecal flora by a new probiotic preparation: preliminary data on
maintenance treatment of patients with ulcerative colitis. Aliment
Pharmacol Ther 1999;13:1103-8.
Wang X, Ma G, Zheng B, Tian H. [Effects of SL-probiotic
preparation on the body weight and phagocytosis of white mice].
Wei Sheng Wu Hsueh Pao 1995;35:455-9.
*These statements have not been evaluated by the Food and Drug Administration.
This product is not intended to diagnose, treat, cure, or prevent any disease.
CHECKOUT
